Literature DB >> 18788843

Intravenous sedation with low-dose dexmedetomidine: its potential for use in dentistry.

Sachie Ogawa1, Hiroaki Seino, Hiroshi Ito, Shinya Yamazaki, Steven Ganzberg, Hiroyoshi Kawaai.   

Abstract

This study investigated the physiologic and sedative parameters associated with a low-dose infusion of dexmedetomidine (Dex). Thirteen healthy volunteers were sedated with Dex at a loading dose of 6 mcg/kg/h for 5 minutes and a continuous infusion dose of 0.2 mcg/kg/h for 25 minutes. The recovery process was observed for 60 minutes post infusion. The tidal volume decreased significantly despite nonsignificant changes in respiratory rate, minute ventilation, oxygen saturation, and end-tidal carbon dioxide. The mean arterial pressure and heart rate also decreased significantly but within clinically acceptable levels. Amnesia to pin prick was present in 69% of subjects. A Trieger dot test plot error ratio did not show a significant change at 30 minutes post infusion despite a continued significant decrease in bispectral index. We conclude that sedation with a low dose of Dex appears to be safe and potentially efficacious for young healthy patients undergoing dental procedures.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18788843      PMCID: PMC2533640          DOI: 10.2344/0003-3006-55.3.82

Source DB:  PubMed          Journal:  Anesth Prog        ISSN: 0003-3006


  21 in total

Review 1.  Clinical uses of alpha2 -adrenergic agonists.

Authors:  T Kamibayashi; M Maze
Journal:  Anesthesiology       Date:  2000-11       Impact factor: 7.892

2.  Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit.

Authors:  R M Venn; C J Bradshaw; R Spencer; D Brealey; E Caudwell; C Naughton; A Vedio; M Singer; R Feneck; D Treacher; S M Willatts; R M Grounds
Journal:  Anaesthesia       Date:  1999-12       Impact factor: 6.955

Review 3.  Gene targeting--homing in on alpha 2-adrenoceptor-subtype function.

Authors:  E MacDonald; B K Kobilka; M Scheinin
Journal:  Trends Pharmacol Sci       Date:  1997-06       Impact factor: 14.819

4.  Perception of pain to three different intraoral penetrations of needles.

Authors:  N P Fuller; R A Menke; W J Meyers
Journal:  J Am Dent Assoc       Date:  1979-11       Impact factor: 3.634

5.  Adverse reactions to local anaesthetic-vasoconstrictor preparations. A study of the cardiovascular responses to Xylestesin and Hostacain-with-Noradrenaline.

Authors:  A J Boakes; D R Laurence; K W Lovel; R O'Neil; P J Verrill
Journal:  Br Dent J       Date:  1972-08-15       Impact factor: 1.626

6.  A comparative study of psychomotor effects of intravenous agents used in dentistry.

Authors:  M G Newman; N Trieger; W J Loskota; A W Jacobs
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1970-07

7.  Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions.

Authors:  R M Venn; R M Grounds
Journal:  Br J Anaesth       Date:  2001-11       Impact factor: 9.166

8.  Controlled sedation with alphaxalone-alphadolone.

Authors:  M A Ramsay; T M Savege; B R Simpson; R Goodwin
Journal:  Br Med J       Date:  1974-06-22

9.  Antinociceptive activity of clonidine and its potentiation of morphine analgesia.

Authors:  T C Spaulding; S Fielding; J J Venafro; H Lal
Journal:  Eur J Pharmacol       Date:  1979-09-01       Impact factor: 4.432

10.  The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects.

Authors:  Laura E Nelson; Jun Lu; Tianzhi Guo; Clifford B Saper; Nicholas P Franks; Mervyn Maze
Journal:  Anesthesiology       Date:  2003-02       Impact factor: 7.892

View more
  8 in total

1.  Dexmedetomidine, ketamine, and midazolam for oral rehabilitation: a case report.

Authors:  Bill W S Kim; Robert M Peskin
Journal:  Anesth Prog       Date:  2015

2.  A comparison of intravenous sedation with two doses of dexmedetomidine: 0.2 µg/kg/hr Versus 0.4 µg/kg/hr.

Authors:  Hiroyoshi Kawaai; Jun Satoh; Masahiro Watanabe; Keiichi Kan; Steven Ganzberg; Shinya Yamazaki
Journal:  Anesth Prog       Date:  2010

3.  Update on dexmedetomidine: use in nonintubated patients requiring sedation for surgical procedures.

Authors:  Mohanad Shukry; Jeffrey A Miller
Journal:  Ther Clin Risk Manag       Date:  2010-04-15       Impact factor: 2.423

4.  Extended infusion of dexmedetomidine to an infant at sixty times the intended rate.

Authors:  Bryan A Max; Keira P Mason
Journal:  Int J Pediatr       Date:  2010-09-08

5.  Safety of Pediatric Peripheral Blood Stem Cell Harvest in Daycare Setting: An Institutional Experience.

Authors:  Melvin Alex Abraham; Anup J Devasia; Sajan Philip George; Biju George; Tunny Sebastian
Journal:  Anesth Essays Res       Date:  2019 Jan-Mar

6.  A Randomized Control Trial of Three Intravenous Dexmedetomidine Doses for Procedural Sedation in Patients Undergoing Minor Gynaecological Surgery.

Authors:  Neha Sharma; Maitree Pandey; Anshu Gupta; Anil Kumar
Journal:  Cureus       Date:  2022-03-19

7.  A Comparison of Oral Midazolam-ketamine, Dexmedetomidine-fentanyl, and Dexmedetomidine-ketamine Combinations as Sedative Agents in Pediatric Dentistry: A Triple-Blinded Randomized Controlled Trial.

Authors:  Astha Jaikaria; Seema Thakur; Parul Singhal; Deepak Chauhan; Cheranjeevi Jayam; Kartik Syal
Journal:  Contemp Clin Dent       Date:  2018-09

8.  Dexmedetomidine-remifentanil vs propofol-remifentanil for monitored anesthesia care during hysteroscopy: Randomized, single-blind, controlled trial.

Authors:  Seongjoo Park; Soo-Lyoen Choi; Francis Sahngun Nahm; Jung-Hee Ryu; Sang-Hwan Do
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.